We are live on ! Find out more
BWP

Baldwin Wealth Partners Portfolio holdings

AUM $1.53B
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+10.65%
1 Year Est. Return
+28.5%
3 Year Est. Return
+85.86%
5 Year Est. Return
+102.78%
10 Year Est. Return
+445.81%
AUM
$915M
AUM Growth
+$73.2M
Cap. Flow
-$7.91M
Cap. Flow %
-0.86%
Top 10 Hldgs %
39.79%
Holding
674
New
46
Increased
95
Reduced
96
Closed
12

Top Buys

Rank Stock Value
1
MAR icon
Marriott International
MAR
+$5.03M
2
EXP icon
Eagle Materials
EXP
+$3.55M
3
JPM icon
JPMorgan Chase
JPM
+$3.2M
4
TIP icon
iShares TIPS Bond ETF
TIP
+$2.38M
5
CVX icon
Chevron
CVX
+$1.57M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$9.95M
2
MKC icon
McCormick & Company Non-Voting
MKC
+$6.94M
3
ECL icon
Ecolab
ECL
+$1.82M
4
BX icon
Blackstone
BX
+$1.54M
5
PEP icon
PepsiCo
PEP
+$1.35M

Sector Composition

Rank Sector Weight
1 Technology 18.56%
2 Financials 16.24%
3 Healthcare 11.84%
4 Communication Services 9.59%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHG icon
226
Philips
PHG
$25.6B
$151K 0.02%
3,688
-296
-7% -$13.7K
BAB icon
227
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$150K 0.02%
4,520
– –
UPST icon
228
Upstart Holdings
UPST
$2.9B
$150K 0.02%
1,200
+700
+140% +$86.1K
WPC icon
229
W.P. Carey
WPC
$16.6B
$149K 0.02%
2,042
– –
ERIC icon
230
Ericsson
ERIC
$33.7B
$148K 0.02%
11,750
+8,750
+292% +$117K
TEVA icon
231
Teva Pharmaceuticals
TEVA
$40.1B
$144K 0.02%
+14,500
New +$153K
DNMR
232
DELISTED
Danimer Scientific, Inc.
DNMR
$144K 0.02%
144
-24
-14% -$23.9K
NOMD icon
233
Nomad Foods
NOMD
$1.68B
$141K 0.02%
5,000
– –
SYNA icon
234
Synaptics
SYNA
$4.16B
$140K 0.02%
900
– –
TYG
235
Tortoise Energy Infrastructure Corp
TYG
$1.08B
$140K 0.02%
4,877
– –
BIIB icon
236
Biogen
BIIB
$30.8B
$139K 0.02%
400
– –
HTD
237
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$912M
$139K 0.02%
5,592
– –
MGM icon
238
MGM Resorts International
MGM
$11.4B
$139K 0.02%
3,250
– –
HIMS icon
239
Hims & Hers Health
HIMS
$7.44B
$138K 0.02%
12,662
+9,629
+317% +$114K
GSK icon
240
GSK
GSK
$103B
$134K 0.01%
2,688
-109
-4% -$5.24K
PLTR icon
241
Palantir
PLTR
$390B
$132K 0.01%
5,000
– –
CIM
242
Chimera Investment
CIM
$1.06B
$131K 0.01%
2,900
– –
BGFV
243
DELISTED
Big 5 Sporting Goods
BGFV
$128K 0.01%
5,000
– –
XYZ
244
Block Inc
XYZ
$50.4B
$128K 0.01%
523
– –
KO icon
245
Coca-Cola
KO
$372B
$126K 0.01%
2,320
-365
-14% -$19.9K
EXAS
246
DELISTED
Exact Sciences
EXAS
$124K 0.01%
1,000
+350
+54% +$41.8K
TOTL icon
247
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.03B
$124K 0.01%
2,553
– –
XAIR icon
248
Beyond Air
XAIR
$4.56M
$123K 0.01%
48
-18
-27% -$39.4K
MRNA icon
249
Moderna
MRNA
$22.8B
$120K 0.01%
510
– –
ZEN
250
DELISTED
ZENDESK INC
ZEN
$120K 0.01%
834
– –
8 9
10
11 12

Similar funds

AF
Atlas FRM Greenwich, Connecticut $1.53B AUM 14.94% 1-Year Est. Return
HR
Howe & Rusling Rochester, New York $1.53B AUM 21.45% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return
FI
FJ Investments Salt Lake City, Utah $1.53B AUM 27.51% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return

Baldwin Wealth Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Baldwin Wealth Partners held 674 positions worth $915M, up 8.7% from $842M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Baldwin Wealth Partners's Q2 2021 filing shows 46 new, 95 increased, 96 reduced and 12 closed positions. Its largest new stake was Eterna Therapeutics: 6 shares worth $795K. The largest sale was Amgen, an estimated $9.95M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Baldwin Wealth Partners's largest Q2 2021 buy was Eterna Therapeutics: 6 shares worth $795K.
  • Baldwin Wealth Partners added most to Marriott International in Q2 2021, an estimated $5.03M increase.
  • Baldwin Wealth Partners's biggest Q2 2021 reduction was Amgen, cutting an estimated $9.95M.
  • Baldwin Wealth Partners fully exited PagSeguro Digital in Q2 2021, selling an estimated $153K.
  • Baldwin Wealth Partners's ten largest holdings make up 40% of its $915M portfolio in Q2 2021.
  • Baldwin Wealth Partners opened 46 new positions and closed 12 in Q2 2021.
  • Baldwin Wealth Partners's portfolio value rose 8.7% quarter-over-quarter to $915M.

Based on Baldwin Wealth Partners's 13F filing for Q2 2021, filed 30 Jul 2021.